Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Cahill Represents Financing Sources in Valeant and Biovail Merger

Date: 06/21/10

Cahill is representing the financing sources in connection with providing $2.8 billion of financing for the merger of specialty pharmaceuticals companies Valeant Pharmaceuticals International and Canada's Biovail Corp.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com